Sartorius AG Vorz-Inhaber-Akt ohne Stimmrecht
SRT3: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€112.00 | Jhk | Grfxwdqyw |
Sartorius AG Earnings: COVID-19 Demand Retreats Along With Profits
Wide-moat Sartorius AG saw a tough start to 2023, as previous COVID-19 tailwinds turned into headwinds relative to the year-ago period, especially in its bioprocessing Sartorius Stedim arm. Management maintained its guidance for 2023. And while we have tinkered with our near-term assumptions, these minor changes did not materially affect our EUR 327 fair value estimate.